MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing Read more about MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing
Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study Read more about Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study
Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab +/- chemotherapy in non-small cell lung cancer (NSCLC) Read more about Early plasma circulating tumor DNA (ctDNA) changes to predict response to first-line pembrolizumab +/- chemotherapy in non-small cell lung cancer (NSCLC)
ctDNA detection in early-stage non-small cell lung cancer Read more about ctDNA detection in early-stage non-small cell lung cancer
Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial Read more about Detection of circulating tumor DNA following neoadjuvant chemotherapy and surgery to anticipate early relapse in ER positive and HER2 negative breast cancer: Analysis from the PENELOPE-B trial
Evaluation of Two Workflows for Variant Detection in Cell-Free DNA Read more about Evaluation of Two Workflows for Variant Detection in Cell-Free DNA
Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer Read more about Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer